Bjorn Thorarinsson, MD
Pulmonary Disease · Ashland, KYNPI 1932206141
Payments from drug & device makers
Across 215 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$800
- GSK$715
- Novartis$577
- Boehringer Ingelheim$317
- Genentech USA, Inc.$258
- Takeda Pharmaceuticals U.S.A., Inc.$168
- plus $798 from 18 others
What the payments were for
- Food & beverage$3,632100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 39 | $800 |
| GSK | 42 | $715 |
| Novartis | 28 | $577 |
| Boehringer Ingelheim | 29 | $317 |
| Genentech USA, Inc. | 17 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $168 |
| Jazz Pharmaceuticals Inc. | 7 | $114 |
| United Therapeutics Corporation | 7 | $104 |
| Pulmonx Corporation | 2 | $95 |
| Electromed, Inc. | 9 | $81 |
| AstraZeneca | 6 | $74 |
| Grifols USA, LLC | 2 | $47 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Mylan Specialty L.p. | 2 | $36 |
| Medical Graphics Corporation | 1 | $34 |
| Shire North American Group Inc | 2 | $29 |
| Circassia Inc. | 2 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Sanofi | 1 | $18 |
| Apria Healthcare LLC | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
| Gilead | 1 | $15 |
| Bayer | 1 | $12 |
How this compares
$3,632 in reported general payments places this provider in the 40th percentile of 226 pulmonary disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Ashland
- Sana GhalibAshland$16K
- Sabrina RobertsAshland$15K
- Scott NelsonAshland$12K
- Mena ShehataAshland$11K
- John McConnellLouisville$3.5M
- Girish NairLexington$852K
- Sally SulimanLouisville$472K
- Mohamed SaadLouisville$440K
- David WinslowLouisville$431K
- Firas KouraGeorgetown$423K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.